Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism.

Authors

• Jia Yi Tan
• Aravinthan Vignarajah
• Yong Hao Yeo, Corewell Health East Resident
• Lay She Ng
• Michael Maroules
• Gunwant Guron
• Robert Kratzke
• Jacob Cogan

Document Type

Article

Publication Date

4-28-2026

Publication Title

British journal of haematology

Recommended Citation

Tan JY, Vignarajah A, Yeo YH, Ng LS, Maroules M, Guron G et al Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism. Br J Haematol. 2026 Apr 28. doi: 10.1111/bjh.70513. Epub ahead of print. PMID: 42047391.

DOI

10.1111/bjh.70513

ISSN

1365-2141

PubMed ID

42047391